The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia
暂无分享,去创建一个
T. Tarragó | E. Giralt | J. Meana | L. Urigüen | S. Royo | E. Munarriz-Cuezva | R. Prades | Laura Mendieta | I. Gil-Pisa | Lídia Gómez | Itziar Gil-Pisa